losartan has been researched along with Extramembranous Glomerulopathy in 4 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with lisinopril and losartan in nephrotic patients with idiopathic membranous nephropathy results in similar (and significant) effects on renal function, hypoalbuminaemia, proteinuria and blood pressure." | 9.14 | Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome. ( Filiopoulos, V; Georgoulias, C; Kosmadakis, G; Michail, S; Tentolouris, N, 2010) |
| "Treatment with lisinopril and losartan in nephrotic patients with idiopathic membranous nephropathy results in similar (and significant) effects on renal function, hypoalbuminaemia, proteinuria and blood pressure." | 5.14 | Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome. ( Filiopoulos, V; Georgoulias, C; Kosmadakis, G; Michail, S; Tentolouris, N, 2010) |
| "Treatment with canagliflozin increased the proportion of Th1 cells by 2." | 1.72 | Canagliflozin reverses Th1/Th2 imbalance and promotes podocyte autophagy in rats with membranous nephropathy. ( Li, J; Lin, Y; Liu, H; Lv, X; Ma, G; Shao, X; Wang, J; Yu, P; Zhang, L; Zhou, S, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, X | 1 |
| Wang, J | 1 |
| Zhang, L | 1 |
| Shao, X | 1 |
| Lin, Y | 1 |
| Liu, H | 1 |
| Ma, G | 1 |
| Li, J | 1 |
| Zhou, S | 1 |
| Yu, P | 1 |
| Kosmadakis, G | 1 |
| Filiopoulos, V | 1 |
| Georgoulias, C | 1 |
| Tentolouris, N | 1 |
| Michail, S | 1 |
| Xu, ZG | 1 |
| Lanting, L | 1 |
| Vaziri, ND | 1 |
| Li, Z | 1 |
| Sepassi, L | 1 |
| Rodriguez-Iturbe, B | 1 |
| Natarajan, R | 1 |
| Yoshimura, J | 1 |
| Kato, S | 1 |
| Tamaki, K | 1 |
| Kohno, K | 1 |
| Kaneyuki, U | 1 |
| Maeda, M | 1 |
| Saikusa-Itoh, Y | 1 |
| Hayashida, A | 1 |
| Iida, S | 1 |
| Suefuji, H | 1 |
| Okuda, S | 1 |
1 trial available for losartan and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
Topics: Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inh | 2010 |
3 other studies available for losartan and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
Canagliflozin reverses Th1/Th2 imbalance and promotes podocyte autophagy in rats with membranous nephropathy.
Topics: Animals; Autophagy; Canagliflozin; Glomerulonephritis, Membranous; Losartan; Podocytes; Rats; Renal | 2022 |
Upregulation of angiotensin II type 1 receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese Zucker rat kidney: reversal by angiotensin II type 1 receptor blockade.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arachidonic Acid; Enzymes | 2005 |
Mesangiolytic glomerulopathy after radiotherapy and chemotherapy of gastric lymphoma.
Topics: Angiotensin II Type 1 Receptor Blockers; Antineoplastic Combined Chemotherapy Protocols; Combined Mo | 2007 |